Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
PD1/PD-L1
>>
Phase 4
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
257
514
771
1028
1285
1542
1799
2056
2313
2570
Keytruda
(pembrolizumab) / Merck (MSD)
Opdivo
(nivolumab) / BMS
AiRuiKa
(camrelizumab) / HLB Bio Group
Tecentriq
(atezolizumab) / Roche
Imfinzi
(durvalumab) / AstraZeneca
Tyvyt
(sintilimab) / Eli Lilly
Tevimbra
(tislelizumab-jsgr) / BeiGene
Loqtorzi
(toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
Kaitanni
(cadonilimab) / Akesobio
Libtayo
(cemiplimab-rwlc) / Regeneron
adebrelimab
(SHR-1316) / Jiangsu Hengrui Pharma
Anniko
(penpulimab) / Akesobio, Sino Biopharm
Enweida
(envafolimab) / 3DMed, Tracon Pharma, Ascletis
Hansizhuang
(serplulimab) / Fosun Pharma
Yutuo
(zimberelimab) / Arcus Biosci, Gilead
benmelstobart
(APL-502) / Apollomics
